Exact Sciences [EXAS] vs Danaher [DHR] Detailed Stock Comparison

Exact Sciences Corp

NASDAQ
Loading...

Danaher Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Exact Sciences Corp wins in 2 metrics, Danaher Corporation wins in 17 metrics, with 0 ties. Danaher Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Exact Sciences Corp Danaher Corporation Better
P/E Ratio (TTM) -95.37 34.61 Danaher Corporation
Price-to-Book Ratio 8.34 2.40 Danaher Corporation
Debt-to-Equity Ratio 105.57 37.17 Danaher Corporation
PEG Ratio 55.22 3.84 Danaher Corporation
EV/EBITDA 302.23 17.69 Danaher Corporation
Profit Margin (TTM) -6.40% 14.89% Danaher Corporation
Operating Margin (TTM) -9.28% 22.94% Danaher Corporation
EBITDA Margin (TTM) N/A 22.94% N/A
Return on Equity -8.66% 7.08% Danaher Corporation
Return on Assets (TTM) -1.59% 4.19% Danaher Corporation
Free Cash Flow (TTM) $356.78M $5.26B Danaher Corporation
Dividend Yield N/A 0.56% N/A
1-Year Return 140.29% -10.25% Exact Sciences Corp
Price-to-Sales Ratio (TTM) 6.17 5.10 Danaher Corporation
Enterprise Value $21.60B $140.38B Danaher Corporation
EV/Revenue Ratio 6.65 5.67 Danaher Corporation
Gross Profit Margin (TTM) 70.11% 60.34% Exact Sciences Corp
Revenue per Share (TTM) $17 $35 Danaher Corporation
Earnings per Share (Diluted) $-1.10 $5.16 Danaher Corporation
Beta (Stock Volatility) 1.44 0.99 Danaher Corporation
Short % of Float 3.92% 1.10% Danaher Corporation

Exact Sciences Corp vs Danaher Corporation Stock Performance Analysis

Loading Price Chart...

EXAS
DHR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Exact Sciences Corp0.00%1.02%1.47%3.27%100.17%3.12%
Danaher Corporation0.56%-1.32%11.85%-5.38%-20.75%-21.40%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Exact Sciences Corp140.29%54.71%-20.87%1,407.33%1,337.12%3,317.26%
Danaher Corporation-10.25%-15.98%-20.94%174.08%416.93%738.84%

Performance & Financial Health Analysis: Exact Sciences Corp vs Danaher Corporation

MetricEXASDHR
Market Information
Market Cap i$20.03B$126.39B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i3,743,5835,174,666
90 Day Avg. Volume i2,715,0144,357,215
Last Close$104.91$181.10
52 Week Range$38.81 - $104.98$160.93 - $242.80
% from 52W High-0.07%-25.41%
All-Time High$159.54 (Jan 25, 2021)$296.06 (Sep 06, 2021)
% from All-Time High-34.24%-38.83%
Growth Metrics
Quarterly Revenue Growth0.23%0.04%
Quarterly Earnings Growth0.23%0.08%
Financial Health
Profit Margin (TTM) i-0.06%0.15%
Operating Margin (TTM) i-0.09%0.23%
Return on Equity (TTM) i-0.09%0.07%
Debt to Equity (MRQ) i105.5737.17
Cash & Liquidity
Book Value per Share (MRQ)$12.58$74.32
Cash per Share (MRQ)$5.05$8.06
Operating Cash Flow (TTM) i$491.44M$6.44B
Levered Free Cash Flow (TTM) i$281.87M$4.57B
Dividends
Last 12-Month Dividend Yield iN/A0.56%
Last 12-Month Dividend iN/A$1.28

Valuation & Enterprise Metrics Analysis: Exact Sciences Corp vs Danaher Corporation

MetricEXAS (Apr 07, 2026)DHR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-95.3734.61
Forward P/E i55.2219.64
PEG Ratio i55.223.84
Price to Sales (TTM) i6.175.10
Price to Book (MRQ) i8.342.40
Market Capitalization
Market Capitalization i$20.03B$126.39B
Enterprise Value i$21.60B$140.38B
Enterprise Value Metrics
Enterprise to Revenue i6.655.67
Enterprise to EBITDA i302.2317.69
Risk & Other Metrics
Beta i1.440.99
Book Value per Share (MRQ) i$12.58$74.32

Financial Statements Comparison: Exact Sciences Corp vs Danaher Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricEXAS (2025)DHR (2025)
Revenue/Sales i3.25B24.57B
Cost of Goods Sold i984.24M10.05B
COGS % of Revenue i30.3%40.9%
Gross Profit i2.26B14.52B
Gross Margin i69.7%59.1%
Research & Development i523.00M1.60B
Operating Income (EBIT) i-199.10M4.69B
Operating Margin i-6.1%19.1%
EBITDA i17.87M7.17B
EBITDA Margin i0.6%29.2%
Pre-Tax Income i-203.89M4.23B
Pre-Tax Income % of Revenue i-6.3%17.2%
Income Tax i4.06M633.00M
Income Tax % of Revenue i0.1%2.6%
Net Income (Profit) i-207.95M3.61B
Profit Margin i-6.4%14.7%

Balance Sheet & Liquidity Metrics

MetricEXAS (2025)DHR (2025)
Cash & Equivalents i956.00M4.62B
Total Current Assets i1.56B12.76B
Total Current Assets % of Revenue i47.9%51.9%
Total Current Liabilities i641.15M6.81B
Total Current Liabilities % of Revenue i19.7%27.7%
Long-Term Debt i2.49B19.50B
Long-Term Debt % of Revenue i76.7%79.4%
Total Shareholders Equity i2.40B52.54B
Retained Earnings i-4.71B46.89B
Retained Earnings % of Revenue i-144.9%190.9%
Property, Plant & Equipment i122.33M2.14B

Cash Flow Statement Comparison

MetricEXAS (2025)DHR (2025)
Operating Cash Flow i273.28M5.64B
Operating Cash Flow % of Revenue i8.4%23.0%
Capital Expenditures i-134.66M-1.12B
Free Cash Flow i356.78M5.26B
FCF Margin i11.0%21.4%
Debt Repayment i-249.17M-500.00M
Common Stock Repurchase iN/A-3.09B

Short Interest & Institutional Ownership Analysis

MetricEXASDHR
Shares Short i7.40M6.94M
Short Ratio i3.231.68
Short % of Float i3.92%1.10%
Shares Outstanding i190.80M707.70M
Float Shares i188.45M630.65M
% Held by Insiders i1.23%10.78%
% Held by Institutions i86.48%85.08%
% Held by Public i12.29%4.14%

Dividend Analysis & Yield Comparison: Exact Sciences Corp vs Danaher Corporation

MetricEXASDHR
Last 12-Month Dividend iN/A$1.28
Last 12-Month Dividend Yield iN/A0.56%
3-Year Avg Annual Dividend iN/A$10.51
3-Year Avg Dividend Yield iN/A1.11%
3-Year Total Dividends iN/A$31.54
Ex-Dividend DateN/ADec 26, 2025